Shanghai Fudan Zhangjiang Bio Pharmaceutical Co (DE:FDY) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co has invested RMB200 million in a low-risk, principal-guaranteed structured deposit product with SPD Bank, using its surplus operational funds. The 58-day investment, linked to the EUR/USD exchange rate, offers an expected annualized return rate between 1.10% and 2.47%, depending on currency fluctuations. This strategic financial move is classified as a disclosable transaction under Hong Kong’s Listing Rules, necessitating a formal announcement but not requiring shareholder approval.
For further insights into DE:FDY stock, check out TipRanks’ Stock Analysis page.
